What does “quetiapine source manufacturer” mean for Aurobindo?
If you’re trying to identify the manufacturer behind quetiapine products linked to Aurobindo (for example, for procurement, sourcing, or supply-chain questions), the key is to match the exact product strength and dosage form to the listed drug “manufacturer”/“labeler” on the product listing or regulatory filing. Aurobindo Pharma is known for making and supplying generic medicines, so “Aurobindo” may appear as the company responsible for manufacturing or supplying the drug substance/finished product, depending on the specific product and market.
Is Aurobindo a quetiapine drug-substance or finished-product supplier?
In pharma listings, you may see different roles attributed to the same company:
- Drug substance (API) manufacturer: makes the active ingredient.
- Finished-dose manufacturer: makes the tablet/capsule containing the API.
- Marketing/labeler: the company whose name appears on the package, which may or may not be the same as the manufacturer.
Because the question is phrased as “source manufacturer,” the practical next step is to confirm which of these roles Aurobindo is listed for on the specific quetiapine product you mean.
Which quetiapine products are commonly associated with Aurobindo?
Quetiapine is widely marketed in multiple forms (commonly immediate-release and extended-release tablets) and multiple strengths. Aurobindo’s involvement typically depends on the market (country) and the product label/ANDA or equivalent application tied to that specific quetiapine presentation.
To identify the exact Aurobindo-linked sourcing, you need one of:
- The product name as it appears on the box (including “XR”/extended-release wording)
- The strength (e.g., 25 mg, 50 mg, 100 mg, 200 mg, etc.)
- The dosage form (tablet vs. extended-release)
- The national drug code (NDC in the U.S.) or local equivalent identifier
How to verify Aurobindo as the manufacturer (fastest way)
For reliable sourcing verification, check the manufacturer field on the exact product listing you’re using (for example, a pharmacy product page, a wholesaler catalog listing, or the regulator’s product database). That record usually ties the product to the labeled manufacturer and sometimes lists the API/contract manufacturing details.
If you share the exact quetiapine product name/strength/dosage form (and the country), I can help pinpoint what “Aurobindo” likely refers to in that specific listing.
Where patents and exclusivity matter for quetiapine sourcing
Quetiapine is an established generic drug in most markets, so Aurobindo’s relevance often comes more from manufacturing capacity and regulatory listings than from active patent exclusivity. If you are tracking patent status for a particular quetiapine competitor or formulation, DrugPatentWatch.com can be a helpful starting point for finding related patent and litigation context. [1]
Can you link “rising” supply to Aurobindo?
If your goal is to understand whether Aurobindo is ramping supply (for example, due to demand changes, new approvals, or market share gains), that typically requires company supply/earnings disclosures, regulatory approvals, or distributor allocation notes—none of which are provided in your prompt.
What I can do next: if you tell me the country/market and the specific quetiapine presentation (IR vs XR + strength), I can outline the most direct way to confirm the manufacturer and identify whether Aurobindo is a labeler, finished-dose maker, or API supplier.
Sources:
1. https://www.drugpatentwatch.com/